153 related articles for article (PubMed ID: 37243721)
41. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.
Hernandez AK; Landis BN; Altundag A; Fjaeldstad AW; Gane S; Holbrook EH; Huart C; Konstantinidis I; Lechner M; Macchi A; Portillo Mazal P; Miwa T; Philpott CM; Pinto JM; Poletti SC; Vodicka J; Welge-Luessen A; Whitcroft KL; Hummel T
ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):312-320. PubMed ID: 37062268
[TBL] [Abstract][Full Text] [Related]
42. Intranasal insulin for COVID-19-related smell loss.
Daniel D; Paula LN; Eduardo BM; Daniel GA; Andrea DE; Fernando LN; Armando MC
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):201-205. PubMed ID: 37608216
[TBL] [Abstract][Full Text] [Related]
43. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
[TBL] [Abstract][Full Text] [Related]
44. [Smell and Taste Dysfunctions owing to COVID-19].
Miwa T
Brain Nerve; 2022 Jul; 74(7):873-878. PubMed ID: 35860934
[TBL] [Abstract][Full Text] [Related]
45. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
Lechien JR; Wajsblat S; Horoi M; Boscolo-Rizzo P; Le Bon SD; Vaira LA; Saussez S
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3461-3467. PubMed ID: 36943439
[TBL] [Abstract][Full Text] [Related]
46. Trigeminal function in patients with COVID-associated olfactory loss.
Juratli JH; Garefis K; Konstantinidis I; Hummel T
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
[TBL] [Abstract][Full Text] [Related]
47. Parosmia and altered taste in patients recovering from Covid 19.
Kelly CE
Clin Nutr Open Sci; 2023 Apr; 48():1-10. PubMed ID: 36514442
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.
Lechien JR; Vaira LA; Saussez S
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1255-1263. PubMed ID: 36153785
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study.
Lechien JR; Saussez S; Vaira LA; De Riu G; Boscolo-Rizzo P; Tirelli G; Michel J; Radulesco T
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):84-91. PubMed ID: 37522295
[TBL] [Abstract][Full Text] [Related]
50. Gustatory dysfunction in patients with olfactory dysfunction and the associated factors.
Rha MS; Cho HJ; Yoon JH; Moon SJ; Kim CH
Rhinology; 2022 Jun; 60(3):200-206. PubMed ID: 35174812
[TBL] [Abstract][Full Text] [Related]
51. A longitudinal study of olfactory dysfunction and parosmia in mild COVID-19 cases.
Monk AS; Bacon DR; Onuorah P; Murr A; Wiesen CA; Oakes J; Thorp BD; Ebert CS; Wohl D; Senior BA; Kimple AJ
Rhinol Online; 2022; 5():168-172. PubMed ID: 37008801
[TBL] [Abstract][Full Text] [Related]
52. Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults.
Sjölund S; Larsson M; Olofsson JK; Seubert J; Laukka EJ
Chem Senses; 2017 May; 42(4):309-318. PubMed ID: 28334095
[TBL] [Abstract][Full Text] [Related]
53. Severe chemotherapy-induced parosmia.
Müller A; Landis BN; Platzbecker U; Holthoff V; Frasnelli J; Hummel T
Am J Rhinol; 2006; 20(4):485-6. PubMed ID: 16955785
[TBL] [Abstract][Full Text] [Related]
54. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
[TBL] [Abstract][Full Text] [Related]
55. Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
Chu M; Gopikrishna D; Rocke J; Kumar BN
Med J Malaysia; 2021 Aug; 76(Suppl 4):9-13. PubMed ID: 34558550
[TBL] [Abstract][Full Text] [Related]
56. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
Lechien JR; Le Bon SD; Saussez S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
[TBL] [Abstract][Full Text] [Related]
57. Clinical Features in Russian Patients with COVID-Associated Parosmia/Phanthosmia.
Kopishinskaia S; Lapshova D; Sherman M; Velichko I; Voznesensky N; Voznesenskaia V
Psychiatr Danub; 2021 Sep; 33(Suppl 9):130-136. PubMed ID: 34559791
[TBL] [Abstract][Full Text] [Related]
58. Intranasal sodium citrate in quantitative and qualitative olfactory dysfunction: results from a prospective, controlled trial of prolonged use in 60 patients.
Whitcroft KL; Gunder N; Cuevas M; Andrews P; Menzel S; Haehner A; Hummel T
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2891-2897. PubMed ID: 33471169
[TBL] [Abstract][Full Text] [Related]
59. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report.
Krimus L; Hasan Rizvi S; Marinov A; Clarke H; Katznelson R
Undersea Hyperb Med; 2023; 50(4):433-435. PubMed ID: 38055885
[TBL] [Abstract][Full Text] [Related]
60. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.
Cancellieri E; Hernandez AK; Degkwitz H; Kahre E; Blankenburg J; Horst TS; Czyborra P; Boscolo-Rizzo P; Hummel T
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
